[Renal transplantation on vascular prosthesis].

Transplantation rénale sur prothèse vasculaire.

Journal

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
ISSN: 1166-7087
Titre abrégé: Prog Urol
Pays: France
ID NLM: 9307844

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 10 01 2019
revised: 29 05 2019
accepted: 13 06 2019
pubmed: 27 8 2019
medline: 27 3 2020
entrez: 27 8 2019
Statut: ppublish

Résumé

In front of a very calcified aortoiliac axis, renal transplantation with implantation of the artery on vascular prosthesis can be proposed. This rare intervention is considered difficult and morbid. The main objective of this work was to evaluate the overall and specific survival of the transplant in this situation. The secondary objective was the study of the complications and the evolution of the transplant's renal function. From a multicenter retrospective data collection of the DIVAT cohort (6 centers) added with data from 4 other transplant centers, we studied transplants with prosthetic arterial anastomosis. Thirty four patients was included. The median duration of follow-up was 2.5 years. 4 patients died in the month following transplantation, 16 were hemodialysis and 9 were transfused. The median survival of the transplant was 212 days. Functional arrests of the transplant were mostly associated with nephrological degradation and return to dialysis (about 80%) while 10% were related to a death of the recipient directly attributable to renal transplantation. The surgical complications of the transplantation were marked by one arterial stenosis, one fistula and 4 urinary stenoses. Thus, renal transplantation with arterial anastomosis on vascular prosthesis, on selected patients, offers an alternative to dialysis. A national compendium of transplanted patients on vascular prosthesis would allow a long-term follow-up of transplant's survival and define selection criteria prior to this kind of surgery. 3.

Identifiants

pubmed: 31447181
pii: S1166-7087(19)30156-3
doi: 10.1016/j.purol.2019.06.005
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

fre

Sous-ensembles de citation

IM

Pagination

603-611

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

M Nédélec (M)

Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, 44093 Nantes, France.

P Glémain (P)

Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, 44093 Nantes, France.

J Rigaud (J)

Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, 44093 Nantes, France.

G Karam (G)

Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, 44093 Nantes, France; Comité de transplantation et d'insuffisance rénale chronique (CTIRC), 75017 Paris, France.

R Thuret (R)

Service d'urologie, CHU de Montpellier, 371, avenue du Doyen-Gaston Giraud, 34295 Montpellier cedex 5, France; Comité de transplantation et d'insuffisance rénale chronique (CTIRC), 75017 Paris, France.

L Badet (L)

Service d'urologie, hôpital Edouard-Herriot, hospices civils de Lyon, 69437 Lyon cedex 03, France; Comité de transplantation et d'insuffisance rénale chronique (CTIRC), 75017 Paris, France.

F Kleinclauss (F)

Service d'urologie, CHRU de Besançon, 25030 Besançon cedex, France; Comité de transplantation et d'insuffisance rénale chronique (CTIRC), 75017 Paris, France.

M O Timsit (MO)

Service d'urologie, hôpital Européen Georges-Pompidou (HEGP), AP-HP, 75015 Paris, France; Comité de transplantation et d'insuffisance rénale chronique (CTIRC), 75017 Paris, France.

J Branchereau (J)

Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, 44093 Nantes, France; Centre de Recherche en Transplantation et Immunologie UMR 1064, Inserm, Université de Nantes, 44093 Nantes, France; Comité de transplantation et d'insuffisance rénale chronique (CTIRC), 75017 Paris, France. Electronic address: julien.branchereau@chu-nantes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH